Systematic review of invasive meningococcal disease: sequelae and quality of life impact on patients and their caregivers KJ Olbrich, D Müller, S Schumacher, E Beck, K Meszaros, F Koerber Infectious diseases and therapy 7, 421-438, 2018 | 147 | 2018 |
A Data-Driven Simulation of HIV Spread Among Young Men Who Have Sex With Men: Role of Age and Race Mixing and STIs EC Beck, M Birkett, B Armbruster, B Mustanski JAIDS Journal of Acquired Immune Deficiency Syndromes 70 (2), 186-194, 2015 | 66 | 2015 |
Cost-effectiveness of 4CMenB infant vaccination in England: a comprehensive valuation considering the broad impact of serogroup B invasive meningococcal disease E Beck, J Klint, M Neine, S Garcia, K Meszaros Value in Health 24 (1), 91-104, 2021 | 27 | 2021 |
Elementary proof of convergence to the mean-field model for the SIR process B Armbruster, E Beck Journal of mathematical biology 75, 327-339, 2017 | 27 | 2017 |
Systematic Literature Review and Quantitative Analysis of Health Problems Associated with Sexually Transmitted Neisseria gonorrhoeae Infection J Whelan, J Eeuwijk, E Bunge, E Beck Infectious Diseases and Therapy 10, 1887-1905, 2021 | 23 | 2021 |
An elementary proof of convergence to the mean-field equations for an epidemic model B Armbruster, E Beck IMA Journal of Applied Mathematics 82 (1), 152-157, 2017 | 19 | 2017 |
Resource management and process change in a simplified model of the emergency department E Beck, H Balasubramanian, PL Henneman Proceedings of the 2009 Winter Simulation Conference (WSC), 1887-1895, 2009 | 19 | 2009 |
Vaccine market access pathways in the EU27 and the United Kingdom− analysis and recommendations for improvements V Laigle, MJ Postma, M Pavlovic, C Cadeddu, E Beck, A Kapusniak, ... Vaccine 39 (39), 5706-5718, 2021 | 17 | 2021 |
Risk factors for cervical cancer in women in China: A meta-model S Aballéa, E Beck, X Cheng, N Demarteau, X Li, F Ma, M Neine, FH Zhao Women's Health 16, 1745506520940875, 2020 | 17 | 2020 |
The potential public health impact of adolescent 4CMenB vaccination on Neisseria gonorrhoeae infection in England: a modelling study KJ Looker, R Booton, N Begum, E Beck, J Shen, KME Turner, ... BMC Public Health 23 (1), 1, 2023 | 15 | 2023 |
Capturing the value of vaccination within health technology assessment and health economics: Country analysis and priority value concepts M Postma, E Biundo, A Chicoye, N Devlin, TM Doherty, AJ Garcia-Ruiz, ... Vaccine 40 (30), 3999-4007, 2022 | 15 | 2022 |
Capturing the value of vaccination within health technology assessment and health economics: Literature review and novel conceptual framework E Beck, E Biundo, N Devlin, TM Doherty, AJ Garcia-Ruiz, M Postma, ... Vaccine 40 (30), 4008-4016, 2022 | 14 | 2022 |
Healthcare resource consumption and cost of invasive meningococcal disease in France: a study of the National Health Insurance Database C Weil-Olivier, MK Taha, C Emery, S Bouée, E Beck, E Aris, ... Infectious diseases and therapy 10 (3), 1607-1623, 2021 | 14 | 2021 |
Long-term mortality and state financial support in invasive meningococcal disease—real-world data analysis using the French national claims database (SNIIRAM) J Shen, S Bouée, E Aris, C Emery, EC Beck Infectious Diseases and Therapy, 1-13, 2022 | 12 | 2022 |
Modelling the impact of 4CMenB and MenACWY meningococcal combined vaccination strategies including potential 4CMenB cross-protection: An application to England E Beck, J Klint, S Garcia, V Abbing, V Abitbol, O Akerborg, L Argante, ... Vaccine 38 (47), 7558-7568, 2020 | 12 | 2020 |
Care pathways in invasive meningococcal disease: a retrospective analysis of the French national public health insurance database C Weil-Olivier, MK Taha, S Bouée, C Emery, V Loncle-Provot, ... Human vaccines & immunotherapeutics 18 (1), 2021764, 2022 | 11 | 2022 |
Public Health Impact and Cost-Effectiveness Analysis of Routine Infant 4CMenB Vaccination in Germany to Prevent Serogroup B Invasive Meningococcal Disease S Scholz, M Schwarz, E Beck, K Meszaros, M Schneider, B Ultsch, ... Infectious Diseases and Therapy, 1-21, 2022 | 9 | 2022 |
The potential clinical impact and cost-effectiveness of the updated COVID-19 mRNA Fall 2023 vaccines in the United States MA Kohli, M Maschio, K Joshi, A Lee, K Fust, E Beck, N Van de Velde, ... Journal of Medical Economics 26 (1), 1532-1545, 2023 | 7 | 2023 |
A discrete event simulation approach to resource management, process changes and task prioritization in emergency departments EC Beck | 7 | 2009 |
PIN43 LIFECYCLE-MODEL-BASED ECONOMIC EVALUATION OF INFANT MENINGITIS B VACCINATION IN THE UK J Sevilla, D Tortorice, D Kantor, DE Bloom, C Hogea, E Beck Value in Health 22, S647, 2019 | 6 | 2019 |